Functional genomics of oxidant-induced lung injury. 2001

G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
Department of Environmental Health, University of Cincinnati, Ohio, USA. leikaugd@uc.edu

In summary, acute lung injury is a severe (>40% mortality) respiratory disease associated with numerous precipitating factors. Despite extensive research since its initial description over 30 years ago, questions remain about the basic pathophysiological mechanisms and their relationship to therapeutic strategies. Histopathology reveals surfactant disruption, epithelial perturbation and sepsis, either as initiating factors or as secondary complications, which in turn increase the expression of cytokines that sequester and activate inflammatory cells, most notably, neutrophils. Concomitant release of reactive oxygen and nitrogen species subsequently modulates endothelial function. Together these events orchestrate the principal clinical manifestations of the syndrome, pulmonary edema and atelectasis. To better understand the gene-environmental interactions controlling this complex process, we examined the relative sensitivity of inbred mouse strains to acute lung injury induced by ozone, ultrafine PTFE, or fine particulate NiSO4 (0.2 microm MMAD, 15-150 microg/m3). Measuring survival time, protein and neutrophils in bronchoalveolar lavage, lung wet: dry weight, and histology, we found that these responses varied between inbred mouse strains, and susceptibility is heritable. To assess the molecular progression of NiSO4-induced acute lung injury, temporal relationships of 8734 genes and expressed sequence tags were assessed by cDNA microarray analysis. Clustering of co-regulated genes (displaying similar temporal expression patterns) revealed the altered expression of relatively few genes. Enhanced expression occurred mainly in genes associated with oxidative stress, anti-proteolytic function, and repair of the extracellular matrix. Concomitantly, surfactant proteins and Clara cell secretory protein mRNA expression decreased. Genome wide analysis of 307 mice generated from the backcross of resistant B6xA F1 with susceptible A strain identified significant linkage to a region on chromosome 6 (proposed as Aliq4) and suggestive linkages on chromosomes 1, 8, and 12. Combining of these QTLs with two additional possible modifying loci (chromosome 9 and 16) accounted for the difference in survival time noted in the A and B6 parental strains. Combining these findings with those of the microarray analysis has enabled prioritization of candidate genes. These candidates, in turn, can be directed to the lung epithelium in transgenic mice or abated in inducible and constitutive gene-targeted mice. Initial results are encouraging and suggest that several of these mice vary in their susceptibility to oxidant-induced lung injury. Thus, these combined approaches have led to new insights into functional genomics of lung injury and diseases.

UI MeSH Term Description Entries
D009532 Nickel A trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.
D010126 Ozone The unstable triatomic form of oxygen, O3. It is a powerful oxidant that is produced for various chemical and industrial uses. Its production is also catalyzed in the ATMOSPHERE by ULTRAVIOLET RAY irradiation of oxygen or other ozone precursors such as VOLATILE ORGANIC COMPOUNDS and NITROGEN OXIDES. About 90% of the ozone in the atmosphere exists in the stratosphere (STRATOSPHERIC OZONE). Ground Level Ozone,Low Level Ozone,Tropospheric Ozone,Level Ozone, Ground,Level Ozone, Low,Ozone, Ground Level,Ozone, Low Level,Ozone, Tropospheric
D011138 Polytetrafluoroethylene Homopolymer of tetrafluoroethylene. Nonflammable, tough, inert plastic tubing or sheeting; used to line vessels, insulate, protect or lubricate apparatus; also as filter, coating for surgical implants or as prosthetic material. Synonyms: Fluoroflex; Fluoroplast; Ftoroplast; Halon; Polyfene; PTFE; Tetron. FEP,Fluon,Politef,Polytef,TFE,Teflon,Expanded PTFE,Fluoroplast,GORE-TEX,Goretex,PTFE,Tarflen,GORE TEX,PTFE, Expanded
D004781 Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. Exposure, Environmental,Environmental Exposures,Exposures, Environmental
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016211 Transforming Growth Factor alpha An EPIDERMAL GROWTH FACTOR related protein that is found in a variety of tissues including EPITHELIUM, and maternal DECIDUA. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form which binds to the EGF RECEPTOR. Epidermal Growth Factor-Related Transforming Growth Factor,TGF-alpha,TGFalpha,Epidermal Growth Factor Related Transforming Growth Factor
D016877 Oxidants Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). Oxidant,Oxidizing Agent,Oxidizing Agents,Agent, Oxidizing,Agents, Oxidizing
D055370 Lung Injury Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES. E-Cigarette Use-Associated Lung Injury,E-Cigarette or Vaping Product Use-Associated Lung Injury,EVALI,Vaping Product Use-Associated Lung Injury,Chronic Lung Injury,Lung Injuries,Pulmonary Injury,Chronic Lung Injuries,E Cigarette Use Associated Lung Injury,E Cigarette or Vaping Product Use Associated Lung Injury,EVALIs,Injuries, Lung,Injuries, Pulmonary,Injury, Lung,Injury, Pulmonary,Lung Injuries, Chronic,Lung Injury, Chronic,Pulmonary Injuries,Vaping Product Use Associated Lung Injury

Related Publications

G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
September 1990, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
July 2010, Proceedings of the American Thoracic Society,
G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
February 1999, European journal of medical research,
G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
November 2003, American journal of respiratory and critical care medicine,
G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
April 2008, Proceedings of the American Thoracic Society,
G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
July 2010, American journal of respiratory and critical care medicine,
G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
November 1981, The Journal of clinical investigation,
G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
January 1986, Respiration; international review of thoracic diseases,
G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
October 1985, Journal of applied toxicology : JAT,
G D Leikauf, and S A McDowell, and C J Bachurski, and B J Aronow, and K Gammon, and S C Wesselkamper, and W Hardie, and J S Wiest, and J E Leikauf, and T R Korfhagen, and D R Prows
August 2006, Seminars in respiratory and critical care medicine,
Copied contents to your clipboard!